Skip to main content
Veterinary Medicines

HatchPak Avinew

Authorised
  • Newcastle disease virus, strain VG/GA, Live

Auðkenning lyfsins

Heiti lyfs:
HatchPak Avinew
HatchPak Avinew sasaldēta suspensija izsmidzināšanai cāļiem
Virkt efni:
Dýrategundir:
  • Kjúklingur (eins dags gamall)
Íkomuleið:

Upplýsingar um lyfið

Virkt efni / Styrkur:
  • Aðeins í boði í English
    5.50
    log 10 50% embryo infective dose
    /
    1.00
    Dose
Lyfjaform:
  • Dreifa í eimgjafa
Withdrawal period by route of administration:
  • Coarse spray
    • Kjúklingur (eins dags gamall)
      • Kjöt og innmatur
        0
        dagar
ATC flokkun (dýralyf):
  • QI01AD06
Staða markaðsleyfis:
  • Gilt
Authorised in:
  • Lettland
Áletrun:

Viðbótarupplýsingar

Entitlement type:
  • Markaðsleyfi
Markaðsleyfishafi:
  • Boehringer Ingelheim Animal Health France
Marketing authorisation date:
Framleiðandi sem ber ábyrgð á lokasamþykkt:
  • Boehringer Ingelheim Animal Health France
Ábyrgt yfirvald:
  • Food And Veterinary Service
Markaðsleyfisnúmer:
  • V/MRP/08/1607
Dagsetning leyfisbreytingar:
Umsjónarland (RMS):
  • Ungverjaland
Númer verkferlis:
  • HU/V/105/001
Þátttökulönd (CMS):
  • Belgía
  • Búlgaría
  • Kýpur
  • Tékkland
  • Frakkland
  • Þýskaland
  • Grikkland
  • Ítalía
  • Lettland
  • Litáen
  • Pólland
  • Rúmenía
  • Slóvakía
  • Slóvenía

Skjöl

Combined File of all Documents

Þetta skjal er ekki til á þessu tungumáli (íslenzkan). Þú getur fundið það á öðru tungumáli hér að neðan.
Latvian (PDF)
Birt á: 8/03/2024
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."